期刊文献+

基于液质联用技术解析和降低螺旋霉素发酵杂质 被引量:2

LC-ESI/MS Identification and Reduction of Impurities in Spiramycin Fermentation
下载PDF
导出
摘要 目前螺旋霉素生物合成的发酵杂质含量过高 ,导致成品收率过低 ,杂质含量不符合药典规定。为解决这一问题 ,首先利用LC -MS联用技术定性分析了 4种螺旋霉素发酵杂质的结构 ,结合螺旋霉素生物合成途径分析 ,它们都起因于螺旋霉素生物合成糖基化过程的紊乱。氮源尤其是铵盐对螺旋霉素生物合成糖基化过程有重要的调节作用。进一步的氮源优化使螺旋霉素发酵液中 4种杂质含量降低 2 2 %~ 88% ,杂质含量全部低于欧洲药典标准。 There are several impurities in the spiramycin fermentation broth whic h leads to a lower yield and lower quality of the product. Four impurities in sp iramycin broth have been simultaneously separated and identified by LC-ESI/MS. T he generation of these impurities was attributed to the fluctuation of glucosyla tion in spiramycin biosynthesis. Nitrogen sources, ammonium in particular, were found to play an important role at the glucosylation. Aided with the information of LC-ESI/MS analysis and subsequent optimization of the culture medium, bette r culture medium of shake flask was designed, which leads to reduction of impuri ties by 22%~88%.
出处 《生物工程学报》 CAS CSCD 北大核心 2005年第2期275-278,共4页 Chinese Journal of Biotechnology
关键词 液质联用 螺旋霉素 杂质 优化 LC-ESI/MS, spiramycin, impurity, optimization
  • 相关文献

参考文献5

  • 1李慧,夏焕章.提高抗生素有效组分产量的生物学方法[J].药物生物技术,2002,9(3):183-186. 被引量:1
  • 2Smith RD, Loo JA, Eemonds CG et al. New developments in biochemical mass spectrometry: electrospray ionization. Anal Chem,1990, 62(9) :882 - 899
  • 3Bradley L. Rapid analysis of antibiotic-containing mixtures from fermentation broths by using liquid chromatography-electrospray ionizatin-mass spectrometry and matrix-assisted laser desorption ionizationtime-of-flight-mass spectrometry. J Am Soc Mass Spectrom, 1996, 7(12): 1227 - 1237
  • 4李友元,陈长华,陶萍.螺旋霉素生物合成中间代谢物的LC-ESI-MS定性分析[J].分析测试学报,2002,21(3):40-43. 被引量:4
  • 5Omura S, Tanaka Y. Stimulation of leucomycin production by magnesium phosphate and its relevance to nitrogen catabolite regulation.Adv Biotechnol[Proc Int Ferment Symp], 6th, 1980, Volume 3,1981, pp. 181 - 186 (English)

二级参考文献21

共引文献3

同被引文献21

  • 1DeBoer C, Meulman PA, Wnuk R J, et al. Geldanamycin, a new antibiotic. J Antibiot (Tokyo), 1970, 23(9): 442-447.
  • 2Hu Z, Liu Y, Tian ZQ, et al. Isolation and characterization of novel geldanamycin analogues. J Antibiot (Tokyo), 2004, 57(7): 421-428.
  • 3Patel K, Piagentini M, Rascher A, et al. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition. Chem Biol, 2004, 11(12): 1625-1633.
  • 4Schnur RC, Corman ML, Gallaschun RJ, et al. erbB-2 oncogene inhibition by geldanamycin derivatives: Synthesis, mechanism of action, and structure-activity relationships. J Med Chem, 1995, 38(19): 3813-3820.
  • 5Rascher A, Hu Z, Viswanathan N, et al. Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRL 3602. FEMS Microbiol Lett, 2003, 218(2): 223-230.
  • 6Rascher A, Hu Z, Buchanan GO, et al. Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption. Appl Environ Microbiol, 2005, 71(8): 4862-4871.
  • 7Hong YS, Lee D, Kim W, et al. Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin. J Am Chem Soc, 2004, 126(36): 11142-1143.
  • 8Shin JC, Na Z, Lee DH, et al. Characterization of tailoring genes involved in the modification of geldanamycin polyketide in Streptornyces hygroscopicus JCM4427. J Microbiol Biotech, 2008, 18(6): 1101-1108.
  • 9Lee D, Lee K, Cai XF, et al. Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: New insight into the formation of the benzoquinone moiety.Chembiochem, 2006, 7(2): 246-248.
  • 10Cullen WP, Jefferson MT, Moyer MP. Process and uses for 4, 5-dihydrogeldanamycin and its hydroquinone: US patent, WO 1993014215. 1993-07-22.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部